Medicinal Chemistry Research

, Volume 27, Issue 2, pp 642–652 | Cite as

Synthesis and anticonvulsant activity of some novel 7-(benzylamino) -1H-benzo[b][1,4]diazepine-2,4(3H, 5H)-dione derivatives

  • Yun-Peng Shao
  • Rong-Bi Han
  • Hui-Fan Wu
  • Feng-Yu Piao
Original Research


A series of novel 7-(benzylamino)-1H-benzo[b][1,4]diazepine-2,4(3H, 5H)-dione derivatives were synthesized and screened for their anticonvulsant activities by the maximal electroshock (MES) test, subcutaneous pentylenetetrazol (scPTZ) test, and their neurotoxicity was evaluated by the rotarod neurotoxicity test (Tox). The study showed that the compound 8c (7-(4-fluorobenzylamino)-1,5-dimethyl-1H-benzo[b][1,4]diazepine-2,4(3H,5H)-dione) was the most promising compound, with median effective dose (ED50) of 36.5 mg/kg, and protective index (PI) values of 4.5 in the MES test. In the scPTZ test, compound 8c also exhibited better anticonvulsant activity (ED50 = 68.2 mg/kg), and the ED50 values of compounds 8c were smaller than that of the reference antiepileptic drugs carbamazepine (ED50 > 100 mg/kg), phenytoin (ED50 > 300 mg/kg), and sodium valproate (ED50 = 149 mg/kg). The possible structure activity relationship was discussed.


1H-benzo[b][1,4]diazepine-2,4(3H,5H)-dione anticonvulsant activity structure-activity relationship 



This work was supported by the National Natural Science Foundation of China (No. 21162031).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.


  1. Adam CE, Thomas S, George L (2005) Curr Top Med Chem 5:15–30CrossRefGoogle Scholar
  2. Arnoldi A, Bonsignori A, Melloni P et al. (1990) J Med Chem 33:2865–2869CrossRefPubMedGoogle Scholar
  3. Bernasconi R, Klein M, Martin P et al. (1988) J Neural Transm 72:213–233CrossRefPubMedGoogle Scholar
  4. Bode JW (2006) Curr Opin Drug Discov Dev 9:765–775Google Scholar
  5. Brodie M (2001) J Epilepsy Res 45:61–64CrossRefGoogle Scholar
  6. Coleman N, Hai MN, Cao Z, Brown BM, Jenkins DP (2014) Neurotherapeutics 12:234–249CrossRefPubMedCentralGoogle Scholar
  7. Cupido T, Tulla-Puche J, Spengler J, Albericio F (2007) Curr Opin Drug Discov Devel 10:768PubMedGoogle Scholar
  8. Dawood KM, Abdel-Gawad H, Rageb EA, Ellithey M, Mohamed HA (2006) Bioorg Med Chem 14:3672–3680CrossRefPubMedGoogle Scholar
  9. Eadie MJ, Vajda F (2012) Antiepileptic drugs. Springer, BerlinGoogle Scholar
  10. Feigenspan A, Bormann J (1994) Proc Natl Acad Sci USA 91:10893–10897CrossRefPubMedPubMedCentralGoogle Scholar
  11. Guerrini G, A Costanzo, G Ciciani, F Bruni, S Selleri, C Costagli, F Besnard, B Costa, C Martini, GD Siena, P Malmberg-Aiello, Bioorg Med. Chem 14 (2006):758–775Google Scholar
  12. Helen CL, Lily YJ (2006) Nat Rev Neurosci 7:548–562CrossRefGoogle Scholar
  13. Jin DC, Zhang W, Piao* FY (2010) Chemistry 2:188–192Google Scholar
  14. Kaur H, Kumar B, Medhi B (2016) Eneurologicalsci 4:42–51CrossRefGoogle Scholar
  15. Krall RL, Penry JK, White BG, Kupferberg HJ, Swinyard EA (1978) Epilepsia 19:409–428CrossRefPubMedGoogle Scholar
  16. Kumar R, Joshi* YC (2008) J Serb Chem Soc 73:937–943CrossRefGoogle Scholar
  17. Loscher W (1982) J Neurochemistr 38:293–295CrossRefGoogle Scholar
  18. Löscher W, Schmidt D (1988) Epilepsy Res 2:145–181CrossRefPubMedGoogle Scholar
  19. Macdonald RL, Barker JL (1978) Neurology 28:325–330CrossRefPubMedGoogle Scholar
  20. Mittapalli GK, Roberts E (2014) Curr Med Chem 21:722–754CrossRefPubMedGoogle Scholar
  21. Moreau S, Coudert P, Rubat C, Vallee-Goyet D, Gardette D, Gramain JC, Couquelet J (1998) Bioorg Med Chem 6:983–991CrossRefPubMedGoogle Scholar
  22. Okada R, Negishi N, Nagaya H (1989) Brain Res 480:383–387CrossRefPubMedGoogle Scholar
  23. Piao* FY, Han RB, Zhang W, Zhang WB, Jiang RS (2011) Eur J Med Chem 46:1050–1055CrossRefPubMedGoogle Scholar
  24. Piao FY, Peng B, Zhang WB et al. (2012) Arzneimittel-Forschung 62:202–207PubMedGoogle Scholar
  25. Piao* FY, Xie YZ, Zhang WB, Zhang W, Han RB (2013) Synthetic Commun 43:1–11CrossRefGoogle Scholar
  26. Porter RJ, Cereghino JJ, Gladding GD, Hessie BJ, Kupferberg HJ, Scoville B (1984) Cleveland Clin. 51:293–305CrossRefGoogle Scholar
  27. Rajarao SJ, Platt B, Sukoff SJ, Lin Q, Bender CN, Nieuwenhuijsen BW, Ring RH, Schechte LE, Rosenzweig-Lipson S, Beyer CE (2007) Neuropeptides 41:307–320CrossRefPubMedGoogle Scholar
  28. Reimers A (2014) Seizure 23:585–591CrossRefPubMedGoogle Scholar
  29. Salvatroe RN, Yoon CH, Jung KW (2011) Tetrahedron 57:7785–7811CrossRefGoogle Scholar
  30. Shang* XF, Yu J, Lin HK (2009) J Coord Chem 62:3951–3960CrossRefGoogle Scholar
  31. Srivastava SK, Singh PM, Bhaduri AP (1999) Synth Commun 29:2085–2091CrossRefGoogle Scholar
  32. Stafstrom CE (2006) J Cereb Blood Flow Metab 26:983–1004CrossRefPubMedGoogle Scholar
  33. Ucar H, Van derpoorten K, Cacciagurra S et al. (1998) J Med Chem 41:1138–1145CrossRefPubMedGoogle Scholar
  34. Valeur* E, Bradley* M (2009) Chem Soc Rev 38:606–631CrossRefPubMedGoogle Scholar
  35. Wei CX, Zhang W, Quan ZS, Han RB, Jiang RS, Piao* FY (2009) Lett Drug Des Discov 6:554–558CrossRefGoogle Scholar
  36. Weinberg LR, Albom MS, Angeles TS et al. (2011) Bioorg Med Chem Lett 21:164–167CrossRefPubMedGoogle Scholar
  37. Zhang WB, Han RB, Zhang W, Jiang RS, Piao* FY (2012) Med Chem Res 21:2587–2594CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Yun-Peng Shao
    • 1
  • Rong-Bi Han
    • 1
    • 2
  • Hui-Fan Wu
    • 1
  • Feng-Yu Piao
    • 1
    • 2
  1. 1.Department of Chemistry, College of ScienceYanbian UniversityYanjiPeople’s Republic of China
  2. 2.Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules (Yanbian University)Ministry of EducationYanjiPeople’s Republic of China

Personalised recommendations